Analysis of Impact on Nasal Obstruction by Commercially Available Internal Nasal Stents
Withdrawn before enrolling
Conditions studied: Nasal Obstruction
In brief
Commercially-available internal nasal stents placed inside the nostril should produce decreased nasal obstruction detectable subjectively (volunteers will fill out a survey) and objectively (degree of obstruction will be measured with a rhinomanometer which measure resistant of airflow while breathing through nose).
Key facts
- Study ID
- NCT00683254
- Run by
- Bethany L. Jones
- People needed
- 0
- Starts
- 2008-05-01
- Expected to finish
- 2008-08-01
- Last updated by the study team
- 2017-05-11
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- 18 years or older
You may not qualify if…
- history of nasal surgery, currently using topical nasal steroid spray, over the counter decongestant, history of recurrent epistaxis or history of nosebleed within 2 weeks prior to data collection, currently pregnant
Where it is running
- University of Iowa Department of Otolaryngology — Iowa City, Iowa, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.